These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 938384)

  • 1. The occurrence of virus in leukocytes of vaccinated chickens following challenge with virulent Newcastle disease virus.
    Turner AJ; Spalatin J; Hanson RP
    Avian Dis; 1976; 20(2):375-81. PubMed ID: 938384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an avirulent Australian strain of Newcastle disease virus as a vaccine.
    Spradbrow PB; Ibrahim AL; Mustaffa-Babjee A; Kim SJ
    Avian Dis; 1978; 22(2):329-35. PubMed ID: 678237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
    King DJ
    Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enzyme-linked immunosorbent assay that measures protective antibody levels to Newcastle disease virus in chickens.
    Wilson RA; Perrotta C; Frey B; Eckroade RJ
    Avian Dis; 1984; 28(4):1079-85. PubMed ID: 6525128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunisation of fancy chickens against Newcastle disease].
    Freund I; Dzapo V; Vielitz E; Redmann T; Kaleta EF
    Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):414-8. PubMed ID: 11721588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral response of in ovo-bursectomized chickens to experimental challenge with velogenic Newcastle disease virus.
    Marino OC; Hanson RP
    Avian Dis; 1987; 31(2):293-301. PubMed ID: 3619822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viscerotropic velogenic Newcastle disease in Turkeys: virus shedding and persistence of infection in susceptible and vaccinated poults.
    Gillette KG; Coria MF; Boney WA; Stone HD
    Avian Dis; 1975; 19(1):31-9. PubMed ID: 1120035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
    Stone H; Mitchell B; Brugh M
    Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of domestic geese to lentogenic and velogenic strains of Newcastle disease virus.
    Bolte AL; Voss M; Vielitz E; Kaleta EF
    Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):155-9. PubMed ID: 11370475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trials of a food-based vaccine to protect village chickens against Newcastle disease.
    Aini I; Ibrahim AL; Spradbrow PB
    Res Vet Sci; 1990 Sep; 49(2):216-9. PubMed ID: 2236920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viscerotropic velogenic Newcastle disease in turkeys: immune response following vaccination with either viable B1 strain or inactivated vaccine.
    Boney WA; Stone HD; Gillette KG; Coria MF
    Avian Dis; 1975; 19(1):19-30. PubMed ID: 1120031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations on the transmissibility of lentogenic strains of Newcastle disease virus: significance of variables.
    Spalatin J; Turner AJ; Hanson RP
    Avian Dis; 1976; 20(2):361-8. PubMed ID: 938383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of the B-1 and VG/GA vaccine strains against velogenic viscerotropic Newcastle disease virus in chickens.
    Beard CW; Villegas P; Glisson JR
    Avian Dis; 1993; 37(1):222-5. PubMed ID: 8452500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory evaluation of Newcastle disease vaccination programs for broiler chickens.
    Giambrone JJ
    Avian Dis; 1985; 29(2):479-87. PubMed ID: 4026739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental infection of vaccinated slaughter ostriches in a natural, open-air feedlot facility with virulent Newcastle disease virus.
    Verwoerd DJ; Olivier A; Gummow B; Gerdes GH; Williams R
    Avian Dis; 1999; 43(3):442-52. PubMed ID: 10494412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serological response and resistance to Newcastle disease in vaccinated poultry].
    Gerganov G; Surtmadzhiev K; Petkov M
    Vet Med Nauki; 1981; 18(8):19-24. PubMed ID: 7340102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Newcastle disease virus carrier state after aerosol vaccination against the disease in chickens of various ages].
    Naneva G
    Vet Med Nauki; 1984; 21(10):11-8. PubMed ID: 6531855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol vaccination against Newcastle disease. I. Studies on particle size.
    Villegas P; Kleven SH
    Avian Dis; 1976; 20(1):179-90. PubMed ID: 1259657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.